A Study of MK0364 in Obese Patients (0364-014)

NCT00131391 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2400

Enrollment

INDUSTRY

Sponsor class

Stopped The overall profile does not support development for obesity

Conditions

Obesity

Interventions

DRUG: Comparator: taranabant
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC